AbbVie (ABBV) Completes Acquisition of Landos

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. PCG
2. NVDA
3. AVGO
4. ALNY
5. CNS
6. EC
7. APO
8. SRE
9. ATTO
10. BRVE

Go back to AbbVie (ABBV) Completes Acquisition of Landos

Deutsche Bank Reiterates Hold Rating on Abbvie (ABBV)

May 24, 2024 8:31 AM EDT

Deutsche Bank analyst James Shin reiterated a Hold rating and $175.00 price target on Abbvie (NYSE: ABBV).

The analyst comments "IMS/IQVIA data for the week ending 5/17/24 show branded Humira with 72.2% share (+0.4% w/w) of Adalimumab scripts. Co-branded Humira (Cordavis x ABBV) captured 9.7% share (+0.2% w/w) of Adalimumab scripts. On a combined basis (branded +... More